Depression in Adolescent Sickle Cell Patients - A 2021 Sudan Study
DOI:
https://doi.org/10.54536/ajhp.v1i1.2144Keywords:
Adolescent, Depression, Sickle Cell Anaemia, Sickle Cell Disease, SudanAbstract
The global mental health crisis, particularly depression, is escalating due to genetic mutations affecting the sixth amino acid, glutamic acid. This cross-sectional study aimed to investigate depression among adolescents with SCA using the Beck Depression Inventory (BDI) between February 2021 and August 2021. This hospital-based cross-sectional study was conducted in Khartoum, Sudan. The study involved 102 SCA patients aged 10-19, with a majority (63.7%) aged 13-16. Depression severity was diagnosed using the Beck Depression Inventory (BDI), and statistical analysis involved chi-square tests to compare proportions between groups, with a significance level of p<0.05 and 95% confidence level. The study found that most males (38.5%) had none-mild depression, while most females (42.0%) had mild-moderate depression with a p-value of 0.310. Age groups showed the highest prevalence of mild-to-moderate depression (46.2%) in 10-12-year-olds and the most mild depression (33.3%) in 17-19-year-olds. Crisis frequency was infrequent among participants (p=0.933). A significant association was observed between crisis frequency and depression severity, with severe depression primarily seen in crisis-prone individuals (27.8%) (p=0.001). The study highlights the global mental illness burden and challenges faced by individuals with SCA, particularly females, emphasizing the need for early psychological support and intervention to improve their well-being.
References
Adam, S. S., Flahiff, C. M., Kamble, S., Telen, M. J., Reed, S. D., & De Castro, L. M. (2017). Depression, quality of life, and medical resource utilization in sickle cell disease. Blood advances, 1(23), 1983-1992.
Alatab, S., Sepanlou, S. G., Ikuta, K., Vahedi, H., Bisignano, C., Safiri, S., Sadeghi, A., Nixon, M. R., Abdoli, A., & Abolhassani, H. (2020). The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet gastroenterology & hepatology, 5(1), 17-30.
Alhomoud, M. A., Gosadi, I. M., & Wahbi, H. A. (2018). Depression among sickle cell anemia patients in the Eastern Province of Saudi Arabia. Saudi Journal of Medicine & Medical Sciences, 6(1), 8.
Ali, E., AlHalwachi, F., Khalil, F., Hejab, Z. M., Almolem, Z., & Mandil, M. (2017). Health-related quality of life in adults with sickle cell disease in the Kingdom of Bahrain (FPRP). Saudi J Med, 2, 3-14.
Arnow, B. A., Hunkeler, E. M., Blasey, C. M., Lee, J., Constantino, M. J., Fireman, B., Kraemer, H. C., Dea, R., Robinson, R., & Hayward, C. (2006). Comorbid depression, chronic pain, and disability in primary care. Psychosomatic medicine, 68(2), 262-268.
Asnani, M. R., Fraser, R., Lewis, N. A., & Reid, M. E. (2010). Depression and loneliness in Jamaicans with sickle cell disease. BMC psychiatry, 10(1), 1-7.
Barakat, L. P., Lash, L. A., Lutz, M. J., & Nicolaou, D. C. (2006). Psychosocial Adaptation of Children and Adolescents With Sickle Cell Disease.
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of general psychiatry, 4(6), 561-571.
Belgrave, F., & Molock, S. D. (1991). The role of depression in hospital admissions and emergency treatment of patients with sickle cell disease. Journal of the National Medical Association, 83(9), 777.
Chakravorty, S., & Williams, T. N. (2015). Sickle cell disease: a neglected chronic disease of increasing global health importance. Archives of disease in childhood, 100(1), 48-53.
Comer, E. W. (2004). Integrating the health and mental health needs of the chronically ill: a group for individuals with depression and sickle cell disease. Social work in health care, 38(4), 57-76.
Currie, S. R., & Wang, J. (2004). Chronic back pain and major depression in the general Canadian population. Pain, 107(1-2), 54-60.
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J., Vos, T., & Whiteford, H. A. (2013). Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS medicine, 10(11), e1001547.
Fu, T. S.-T., Lee, C.-S., Gunnell, D., Lee, W.-C., & Cheng, A. T.-A. (2013). Changing trends in the prevalence of common mental disorders in Taiwan: a 20-year repeated cross-sectional survey. The Lancet, 381(9862), 235-241.
Gil, K. M., Abrams, M. R., Phillips, G., & Keefe, F. J. (1989). Sickle cell disease pain: relation of coping strategies to adjustment. Journal of Consulting and Clinical Psychology, 57(6), 725.
Graves, J. K., Hodge, C., & Jacob, E. (2016). Depression, anxiety, and quality of life in children and adolescents with sickle cell disease. Pediatric nursing, 42(3), 113.
Hamideh, D., & Alvarez, O. (2013). Sickle cell disease related mortality in the United States (1999–2009). Pediatric blood & cancer, 60(9), 1482-1486.
Hasan, S. P., Hashmi, S., Alhassen, M., Lawson, W., & Castro, O. (2003). Depression in sickle cell disease. Journal of the National Medical Association, 95(7), 533.
Jenerette, C., Funk, M., & Murdaugh, C. (2005). Sickle cell disease: a stigmatizing condition that may lead to depression. Issues in Mental Health Nursing, 26(10), 1081-1101.
Jiya, F. B., Jiya, N. M., Ibitoye, P. K., Garba, B. I., Baba, J., Adamu, A. u., & Isezuo, K. O. Depressive symptoms among in-school adolescents in north-western Nigeria.
Jonassaint, C. R., Jones, V. L., Leong, S., & Frierson, G. M. (2016). A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease. British journal of haematology, 174(1), 136-147.
Lanzkron, S., Carroll, C. P., & Haywood Jr, C. (2013). Mortality rates and age at death from sickle cell disease: US, 1979–2005. Public health reports, 128(2), 110-116.
Leavell, S. R., & Ford, C. V. (1983). Psychopathology in patients with sickle cell disease. Psychosomatics, 24(1), 23-37.
Levenson, J. L., McClish, D. K., Dahman, B. A., Bovbjerg, V. E., Citero, V. d. A., Penberthy, L. T., Aisiku, I. P., Roberts, J. D., Roseff, S. D., & Smith, W. R. (2008). Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosomatic medicine, 70(2), 192-196.
Makani, J., Ofori-Acquah, S., Nnodu, O., Wonkam, A., & Ohene-Frempong, K. (2013). Sickle cell disease: new opportunities and challenges in Africa. The scientific world journal, 2013.
Molock, S. D., & Belgrave, F. Z. (1994). Depression and anxiety in patients with sickle cell disease: conceptual and methodological considerations. Journal of Health & Social Policy, 5(3-4), 39-53.
Murray, C. J., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., & Abdalla, S. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2197-2223.
Ngwengi, N. Y., Fon, P. N., & Mbanya, D. (2020). Distribution of haemoglobin genotypes, knowledge, attitude and practices towards sickle cell disease among unmarried youths in the Buea Health District, Cameroon. The Pan African Medical Journal, 37.
Novelli, E. M., & Gladwin, M. T. (2016). Crises in sickle cell disease. Chest, 149(4), 1082-1093.
Ohayon, M. M., & Schatzberg, A. F. (2003). Using chronic pain to predict depressive morbidity in the general population. Archives of general psychiatry, 60(1), 39-47.
Oppong, M., Lamptey, H., Kyei-Baafour, E., Aculley, B., Ofori, E. A., Tornyigah, B., Kweku, M., & Ofori, M. F. (2020). Prevalence of sickle cell disorders and malaria infection in children aged 1–12 years in the Volta Region, Ghana: a community-based study. Malaria journal, 19(1), 1-11.
Piel, F. B., Patil, A. P., Howes, R. E., Nyangiri, O. A., Gething, P. W., Dewi, M., Temperley, W. H., Williams, T. N., Weatherall, D. J., & Hay, S. I. (2013). Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. The Lancet, 381(9861), 142-151.
Sehlo, M. G., & Kamfar, H. Z. (2015). Depression and quality of life in children with sickle cell disease: the effect of social support. BMC psychiatry, 15(1), 1-8.
Simon, E., Long, B., & Koyfman, A. (2016). Emergency medicine management of sickle cell disease complications: an evidence-based update. The Journal of emergency medicine, 51(4), 370-381.
Smith, W. R., Penberthy, L. T., Bovbjerg, V. E., McClish, D. K., Roberts, J. D., Dahman, B., Aisiku, I. P., Levenson, J. L., & Roseff, S. D. (2008). Daily assessment of pain in adults with sickle cell disease. Annals of internal medicine, 148(2), 94-101.
Zorca, S., Freeman, L., Hildesheim, M., Allen, D., Remaley, A. T., Taylor, J. G., & Kato, G. J. (2010). Lipid levels in sickle‐cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. British journal of haematology, 149(3), 436-445.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sahar Moawia Balla Elnour, Fatima Hassan Salman, Ziryab Elmahdi
This work is licensed under a Creative Commons Attribution 4.0 International License.
